Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Genet Med ; 26(4): 101068, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38193396

ABSTRACT

PURPOSE: Widespread application of next-generation sequencing, combined with data exchange platforms, has provided molecular diagnoses for countless families. To maximize diagnostic yield, we implemented an unbiased semi-automated genematching algorithm based on genotype and phenotype matching. METHODS: Rare homozygous variants identified in 2 or more affected individuals, but not in healthy individuals, were extracted from our local database of ∼12,000 exomes. Phenotype similarity scores (PSS), based on human phenotype ontology terms, were assigned to each pair of individuals matched at the genotype level using HPOsim. RESULTS: 33,792 genotype-matched pairs were discovered, representing variants in 7567 unique genes. There was an enrichment of PSS ≥0.1 among pathogenic/likely pathogenic variant-level pairs (94.3% in pathogenic/likely pathogenic variant-level matches vs 34.75% in all matches). We highlighted founder or region-specific variants as an internal positive control and proceeded to identify candidate disease genes. Variant-level matches were particularly helpful in cases involving inframe indels and splice region variants beyond the canonical splice sites, which may otherwise have been disregarded, allowing for detection of candidate disease genes, such as KAT2A, RPAIN, and LAMP3. CONCLUSION: Semi-automated genotype matching combined with PSS is a powerful tool to resolve variants of uncertain significance and to identify candidate disease genes.


Subject(s)
Genotype , Humans , Phenotype , Mutation , Homozygote , Genetic Association Studies
2.
Life Sci Alliance ; 5(10)2022 10.
Article in English | MEDLINE | ID: mdl-35981887

ABSTRACT

Histone acetylation levels are reduced during mitosis. To study the mitotic regulation of H3K9ac, we used an array of inhibitors targeting specific histone deacetylases. We evaluated the involvement of the targeted enzymes in regulating H3K9ac during all mitotic stages by immunofluorescence and immunoblots. We identified HDAC2, HDAC3, and SIRT1 as modulators of H3K9ac mitotic levels. HDAC2 inhibition increased H3K9ac levels in prophase, whereas HDAC3 or SIRT1 inhibition increased H3K9ac levels in metaphase. Next, we performed ChIP-seq on mitotic-arrested cells following targeted inhibition of these histone deacetylases. We found that both HDAC2 and HDAC3 have a similar impact on H3K9ac, and inhibiting either of these two HDACs substantially increases the levels of this histone acetylation in promoters, enhancers, and insulators. Altogether, our results support a model in which H3K9 deacetylation is a stepwise process-at prophase, HDAC2 modulates most transcription-associated H3K9ac-marked loci, and at metaphase, HDAC3 maintains the reduced acetylation, whereas SIRT1 potentially regulates H3K9ac by impacting HAT activity.


Subject(s)
Histones , Sirtuin 1 , Acetylation , Histones/metabolism , Mitosis/genetics , Protein Processing, Post-Translational , Sirtuin 1/genetics
4.
EMBO J ; 22(14): 3602-12, 2003 Jul 15.
Article in English | MEDLINE | ID: mdl-12853475

ABSTRACT

The Wiskott-Aldrich syndrome related protein WAVE2 is implicated in the regulation of actin-cytoskeletal reorganization downstream of the small Rho GTPase, Rac. We inactivated the WAVE2 gene by gene-targeted mutation to examine its role in murine development and in actin assembly. WAVE2-deficient embryos survived until approximately embryonic day 12.5 and displayed growth retardation and certain morphological defects, including malformations of the ventricles in the developing brain. WAVE2-deficient embryonic stem cells displayed normal proliferation, whereas WAVE2-deficient embryonic fibroblasts exhibited severe growth defects, as well as defective cell motility in response to PDGF, lamellipodium formation and Rac-mediated actin polymerization. These results imply a non-redundant role for WAVE2 in murine embryogenesis and a critical role for WAVE2 in actin-based processes downstream of Rac that are essential for cell movement.


Subject(s)
Actins/metabolism , Cell Movement/physiology , Embryo, Mammalian/physiology , Microfilament Proteins/deficiency , Microfilament Proteins/metabolism , rac GTP-Binding Proteins/metabolism , Actins/physiology , Animals , Biopolymers , Cell Line , Cytoskeleton/metabolism , Embryo, Mammalian/cytology , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Deletion , Mice , Mice, Knockout , Microfilament Proteins/genetics , Mutation , Protein Isoforms/deficiency , Protein Isoforms/genetics , Protein Isoforms/metabolism , Pseudopodia/metabolism , RNA/metabolism , Stem Cells/cytology , Stem Cells/metabolism , Wiskott-Aldrich Syndrome/blood , Wiskott-Aldrich Syndrome/metabolism , Wiskott-Aldrich Syndrome Protein Family
5.
Nature ; 418(6899): 790-3, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12181570

ABSTRACT

Rac signalling to actin -- a pathway that is thought to be mediated by the protein Scar/WAVE (WASP (Wiskott-Aldrich syndrome protein)-family verprolin homologous protein -- has a principal role in cell motility. In an analogous pathway, direct interaction of Cdc42 with the related protein N-WASP stimulates actin polymerization. For the Rac-WAVE pathway, no such direct interaction has been identified. Here we report a mechanism by which Rac and the adapter protein Nck activate actin nucleation through WAVE1. WAVE1 exists in a heterotetrameric complex that includes orthologues of human PIR121 (p53-inducible messenger RNA with a relative molecular mass (M(r)) of 140,000), Nap125 (NCK-associated protein with an M(r) of 125,000) and HSPC300. Whereas recombinant WAVE1 is constitutively active, the WAVE1 complex is inactive. We therefore propose that Rac1 and Nck cause dissociation of the WAVE1 complex, which releases active WAVE1-HSPC300 and leads to actin nucleation.


Subject(s)
Actins/metabolism , Adaptor Proteins, Signal Transducing , Microfilament Proteins/metabolism , Oncogene Proteins/metabolism , rac1 GTP-Binding Protein/metabolism , Animals , Carrier Proteins/metabolism , Cattle , Humans , Macromolecular Substances , Microfilament Proteins/genetics , Microfilament Proteins/isolation & purification , Oncogene Proteins/genetics , Protein Binding , Signal Transduction , Wiskott-Aldrich Syndrome , Wiskott-Aldrich Syndrome Protein Family , rac1 GTP-Binding Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...